FDA greenlights telethermographic systems’ use for COVID-19 triage

The Food and Drug Administration issued guidance expanding the use of telethermographic systems for triage use during the public health crisis. Because fever is a common symptom of the virus, FDA says that telethermographic systems, which convert infrared radiation into body temperature measurement, can be deployed to use for initial triage at high-traffic areas, such as airports, businesses, warehouses and factories, as well as in settings where thermometers may be in short supply.